Clinical value of Tiam1-Rac1 signaling in primary gallbladder carcinoma

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1873-1878

  Du, Xilin ^a   Wang, Shengzhi ^a   Lu, Jianguo ^a   Wang, Qing ^a   Song, Nuan ^a   Yang, Tao ^a   Dong, Rui ^a   Zang, Li ^a   Yang, Yuan ^a   Wu, Tao ^a   Wang, Chengguo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Primary gallbladder carcinoma; Prognosis; Rac1; Tiam1

Indexed keywords

PROTEIN; RAC1 PROTEIN; TIAM1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL TIME;

CARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84872822013     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0046-2     Document Type: Article

References (27)

1. Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-76.
2. Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17:174-80.
3. Strumane K, Rygiel T, van der Valk M, et al. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice. J Cancer Res Clin Oncol. 2009;135:69-80.
4. Itoh RE, Kiyokawa E, Aoki K, et al. Phosphorylation and activation of the Rac1 and Cdc42 GEF Asef in A431 cells stimulated by EGF. J Cell Sci. 2008;121(Pt 16):2635-42.
5. Gao Y, Dickerson JB, Guo F, et al. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA. 2004;101:7618-23.
6. Qin L, Zhang M. Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway. J Biol Chem. 2010;285:32360-9.
7. Yang W, Lv S, Liu X, et al. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma. Jpn J Clin Oncol. 2010;40:1053-9.
8. Qi Y, Huang B, Yu L, et al. Prognostic value of Tiam1 and Rac1 overexpression in nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec. 2009;71:163-71.
9. Hamilton SR, Alatonen LA. World health organization classification of tumours. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2004.
10. Greene FL, Page DL, Fleming ID. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
11. Wang SJ, Kalpathy-Cramer J, Kim JS, et al. Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer. AMIA Annu Symp Proc. 2010;2010: 847-51.
12. Justilien V, Fields AP. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene. 2009;28:3597-607.
13. Wang Z, Jin H, Xu R, et al. Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med. 2009;41:717-27.
14. Basu A, Haldar S. Anti-proliferative and proapoptotic effects of benzyl isothiocyanate on human pancreatic cancer cells is linked to death receptor activation and RasGAP/Rac1 down-modulation. Int J Oncol. 2009;35:593-9.
15. Engers R, Zwaka TP, Gohr L, et al. Tiam1 mutations in human renal-cell carcinomas. Int J Cancer. 2000;88:369-76.
16. Binker MG, Binker-Cosen AA, Richards D, et al. EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2. Biochem Biophys Res Commun. 2009;379:445-50.
17. Singleton PA, Dudek SM, Chiang ET, et al. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 2005;19:1646-56.
18. Hou M, Tan L, Wang X, et al. Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro. Acta Biochim Biophys Sin (Shanghai). 2004;36:537-40.
19. Otsuki Y, Tanaka M, Yoshii S, et al. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci USA. 2001;98:4385-90.
20. Adams HC 3rd, Chen R, Liu Z, et al. Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasisinducing protein. Breast Cancer Res. 2010;12:R69.
21. Cruz-Monserrate Z, O'Connor KL. Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1 upregulation, and subsequent Rac activation. Neoplasia. 2008;10:408-17.
22. Singleton PA, Salgia R, Moreno-Vinasco L, et al. CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. J Biol Chem. 2007;282:30643-57.
23. Stebel A, Brachetti C, Kunkel M, et al. Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1. Oncol Rep. 2009;21:217-22.
24. Cao H, Shibayama-Imazu T, Masuda Y, et al. Involvement of Tiam1 in apoptosis induced by bufalin in HeLa cells. Anticancer Res. 2007;27:245-9.
25. Adithi M, Venkatesan N, Kandalam M, et al. Expressions of Rac1, Tiam1 and Cdc42 in retinoblastoma. Exp Eye Res. 2006;83:1446-52.
26. Engers R, Springer E, Michiels F, et al. Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem. 2001;276:41889-97.
27. Zhu H, Shan L, Peng T. Rac1 mediates sex difference in cardiac tumor necrosis factor-alpha expression via NADPH oxidase-ERK1/2/p38 MAPK pathway in endotoxemia. J Mol Cell Cardiol. 2009;47:264-74.